Portfolio Holdings Detail for ISIN IE00BF4RFH31
Stock Name / FundiShares MSCI World Small Cap UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerWSML(USD) LSE
ETF TickerWLDS(GBP) LSE
ETF TickerIUSN(EUR) F
ETF TickerIUSN.DE(EUR) CXE
ETF TickerWLDS.LS(GBP) CXE
ETF TickerWSML.LS(USD) CXE
ETF TickerWSML.L(GBP) LSE
ETF TickerWLDS.L(GBP) LSE

Holdings detail for CLBT

Stock NameCellebrite DI
TickerCLBT(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINIL0011794802

Show aggregate CLBT holdings

News associated with CLBT

Cellebrite DI Ltd. (NASDAQ:CLBT) Receives $22.40 Average PT from Brokerages
Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) has been given a consensus recommendation of “Buy” by the five research firms that are presently covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy rating. The average 1 year price objective among brokers that have covered the stock […] - 2025-09-17 02:42:45
Cellebrite DI Ltd. (NASDAQ:CLBT) Given Consensus Rating of “Buy” by Brokerages
Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) has earned a consensus recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat reports. Five equities research analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have issued ratings on the stock in […] - 2025-08-20 02:38:43
Company News for Aug 15, 2025
Companies In The News Are: DE, DLO, AMCR, CLBT. - 2025-08-15 03:44:00
Natixis Advisors LLC Takes $469,000 Position in Cellebrite DI Ltd. (NASDAQ:CLBT)
Natixis Advisors LLC bought a new stake in Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) in the 1st quarter, Holdings Channel.com reports. The firm bought 24,131 shares of the company’s stock, valued at approximately $469,000. Other institutional investors and hedge funds have also made changes to their positions in the company. Assetmark Inc. purchased a […] - 2025-08-12 04:38:46
Cellebrite DI (NASDAQ:CLBT) Stock Rating Lowered by Wall Street Zen
Wall Street Zen cut shares of Cellebrite DI (NASDAQ:CLBT – Free Report) from a buy rating to a hold rating in a research report report published on Saturday. A number of other brokerages have also weighed in on CLBT. JPMorgan Chase & Co. dropped their price target on Cellebrite DI from $29.00 to $25.00 and […] - 2025-08-05 02:13:00
Teacher Retirement System of Texas Acquires 24,337 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)
Teacher Retirement System of Texas grew its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 121.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 44,407 shares of the company’s stock after buying an additional 24,337 shares during […] - 2025-07-15 05:09:26
OneDigital Investment Advisors LLC Has $556,000 Position in Cellebrite DI Ltd. (NASDAQ:CLBT)
OneDigital Investment Advisors LLC increased its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 2.5% during the 1st quarter, Holdings Channel.com reports. The fund owned 28,591 shares of the company’s stock after acquiring an additional 688 shares during the period. OneDigital Investment Advisors LLC’s holdings in Cellebrite DI were worth $556,000 […] - 2025-07-10 06:04:47
Calamos Advisors LLC Decreases Position in Cellebrite DI Ltd. (NASDAQ:CLBT)
Calamos Advisors LLC trimmed its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 63.9% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 38,642 shares of the company’s stock after selling 68,337 shares during the period. Calamos Advisors LLC’s holdings in […] - 2025-07-07 05:58:55
Brokerages Set Cellebrite DI Ltd. (NASDAQ:CLBT) Price Target at $22.43
Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) have received a consensus rating of “Buy” from the seven research firms that are currently covering the company, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have issued ratings on […] - 2025-07-04 02:22:50
Robeco Institutional Asset Management B.V. Invests $3.84 Million in Cellebrite DI Ltd. (NASDAQ:CLBT)
Robeco Institutional Asset Management B.V. purchased a new stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 197,554 shares of the company’s stock, valued at approximately $3,838,000. Robeco Institutional Asset […] - 2025-07-01 05:32:54
Manning & Napier Advisors LLC Makes New Investment in Cellebrite DI Ltd. (NASDAQ:CLBT)
Manning & Napier Advisors LLC acquired a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) in the first quarter, Holdings Channel reports. The fund acquired 101,848 shares of the company’s stock, valued at approximately $1,979,000. Other hedge funds also recently added to or reduced their stakes in the company. Gen Wealth […] - 2025-06-24 05:46:49
Cellebrite DI Ltd. (NASDAQ:CLBT) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 32.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 148,132 shares of the company’s stock […] - 2025-06-06 05:16:58
Cellebrite DI Ltd. (NASDAQ:CLBT) Given Average Recommendation of “Buy” by Brokerages
Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) have been given an average rating of “Buy” by the seven research firms that are currently covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued ratings on the stock […] - 2025-06-06 02:54:54
Mackenzie Financial Corp Invests $776,000 in Cellebrite DI Ltd. (NASDAQ:CLBT)
Mackenzie Financial Corp purchased a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 35,217 shares of the company’s stock, valued at approximately $776,000. Other large investors also recently made changes to their positions in the company. Raymond James Financial Inc. bought […] - 2025-06-02 05:48:55
Cellebrite DI Ltd. (NASDAQ:CLBT) Shares Purchased by Bank of America Corp DE
Bank of America Corp DE raised its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 32.0% in the 4th quarter, HoldingsChannel reports. The fund owned 680,375 shares of the company’s stock after acquiring an additional 165,116 shares during the period. Bank of America Corp DE’s holdings in Cellebrite DI were worth $14,989,000 at […] - 2025-05-22 05:30:55
Needham & Company LLC Issues Pessimistic Forecast for Cellebrite DI (NASDAQ:CLBT) Stock Price
Cellebrite DI (NASDAQ:CLBT – Get Free Report) had its price objective lowered by investment analysts at Needham & Company LLC from $28.00 to $24.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s price objective would suggest a potential upside […] - 2025-05-16 04:59:11
Cellebrite DI (NASDAQ:CLBT) Shares Gap Down After Analyst Downgrade
Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report)’s stock price gapped down prior to trading on Wednesday after Needham & Company LLC lowered their price target on the stock from $28.00 to $24.00. The stock had previously closed at $20.12, but opened at $16.91. Needham & Company LLC currently has a buy rating on the […] - 2025-05-16 02:16:56
JPMorgan Chase & Co. Lowers Cellebrite DI (NASDAQ:CLBT) Price Target to $25.00
Cellebrite DI (NASDAQ:CLBT – Free Report) had its target price cut by JPMorgan Chase & Co. from $29.00 to $25.00 in a research report sent to investors on Monday morning,Benzinga reports. They currently have an overweight rating on the stock. A number of other research firms have also weighed in on CLBT. Needham & Company […] - 2025-05-15 02:44:43
CLBT Makes Notable Cross Below Critical Moving Average
In trading on Wednesday, shares of Cellebrite DI Ltd (Symbol: CLBT) crossed below their 200 day moving average of $18.99, changing hands as low as $16.60 per share. Cellebrite DI Ltd shares are currently trading down about 12.9% on the day. The chart below shows the one year p - 2025-05-14 12:56:46
Notable ETF Inflow Detected - SCZ, TIGO, ODD, CLBT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI EAFE Small-Cap ETF (Symbol: SCZ) where we have detected an approximate $243.5 million dollar inflow -- that's a 2.6% increase week over - 2025-05-09 11:54:18
NewEdge Advisors LLC Has $86,000 Stock Position in Cellebrite DI Ltd. (NASDAQ:CLBT)
NewEdge Advisors LLC increased its stake in Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 600.7% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 3,910 shares of the company’s stock after purchasing an additional 3,352 shares during the quarter. NewEdge Advisors LLC’s holdings in Cellebrite DI were worth $86,000 as of its most […] - 2025-05-04 05:42:48
Noteworthy ETF Outflows: SCZ, CLBT, ODD, INMD
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI EAFE Small-Cap ETF (Symbol: SCZ) where we have detected an approximate $172.9 million dollar outflow -- that's a 1.8% decrease week ove - 2025-05-01 12:46:40
Head to Head Analysis: Cellebrite DI (NASDAQ:CLBT) versus Intellicheck (NYSE:IDN)
Intellicheck (NYSE:IDN – Get Free Report) and Cellebrite DI (NASDAQ:CLBT – Get Free Report) are both industrials companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, analyst recommendations, profitability and institutional ownership. Analyst Ratings This is a summary of current ratings […] - 2025-04-24 02:28:50
Legal & General Group Plc Purchases 36,949 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)
Legal & General Group Plc boosted its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 30.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 160,223 shares of the company’s stock after buying an additional 36,949 shares during the period. Legal & […] - 2025-04-23 05:21:01
JPMorgan Chase & Co. Has $7.31 Million Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)
JPMorgan Chase & Co. trimmed its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 22.4% in the 4th quarter, Holdings Channel reports. The institutional investor owned 331,665 shares of the company’s stock after selling 95,990 shares during the period. JPMorgan Chase & Co.’s holdings in Cellebrite DI were worth $7,307,000 as […] - 2025-04-17 04:27:15
Cellebrite DI Ltd. (NASDAQ:CLBT) Shares Acquired by Sei Investments Co.
Sei Investments Co. increased its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 43.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 408,043 shares of the company’s stock after buying an additional 124,558 shares during the quarter. […] - 2025-03-31 04:48:59
Noteworthy ETF Inflows: SCZ, ZIM, CLBT, ODD
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI EAFE Small-Cap ETF (Symbol: SCZ) where we have detected an approximate $390.8 million dollar inflow -- that's a 4.4% increase week over - 2025-03-24 12:51:29
We Did The Math SMLF Can Go To $82
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-19 08:58:00
Cellebrite DI (NASDAQ:CLBT) Receives Buy Rating from Needham & Company LLC
Cellebrite DI (NASDAQ:CLBT – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Needham & Company LLC in a note issued to investors on Monday,Benzinga reports. They currently have a $28.00 target price on the stock. Needham & Company LLC’s price objective suggests a potential upside of 62.51% from the stock’s […] - 2025-03-12 04:08:56
Principal Financial Group Inc. Sells 334,666 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)
Principal Financial Group Inc. reduced its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 24.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,054,988 shares of the company’s stock after selling 334,666 shares during the quarter. Principal Financial Group Inc.’s […] - 2025-02-24 06:50:55

iShares MSCI World Small Cap UCITS ETF USD (Acc) CLBT holdings

DateNumber of CLBT Shares HeldBase Market Value of CLBT SharesLocal Market Value of CLBT SharesChange in CLBT Shares HeldChange in CLBT Base ValueCurrent Price per CLBT Share HeldPrevious Price per CLBT Share Held
2025-10-15 (Wednesday)75,099USD 1,449,411USD 1,449,411
2025-10-10 (Friday)74,637USD 1,425,567USD 1,425,567
2025-10-08 (Wednesday)74,637USD 1,417,357USD 1,417,357
2025-10-07 (Tuesday)74,637CLBT holding increased by 308USD 1,380,038CLBT holding decreased by -16976USD 1,380,038308USD -16,976 USD 18.49 USD 18.795
2025-10-06 (Monday)74,329USD 1,397,014CLBT holding increased by 13008USD 1,397,0140USD 13,008 USD 18.795 USD 18.62
2025-10-03 (Friday)74,329USD 1,384,006CLBT holding decreased by -10778USD 1,384,0060USD -10,778 USD 18.62 USD 18.765
2025-10-02 (Thursday)74,329USD 1,394,784CLBT holding increased by 19697USD 1,394,7840USD 19,697 USD 18.765 USD 18.5
2025-10-01 (Wednesday)74,329USD 1,375,087CLBT holding decreased by -2229USD 1,375,0870USD -2,229 USD 18.5 USD 18.53
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CLBT by Blackrock for IE00BF4RFH31

Show aggregate share trades of CLBT

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-07BUY308 18.490* 18.54
2025-08-15BUY310 15.600* 18.55
2025-08-07BUY930 13.820* 18.60
2025-07-29BUY308 14.490* 18.76
2025-07-14BUY620 14.620* 18.93
2025-06-30BUY616 16.000* 19.09
2025-06-25BUY924 16.240* 19.15
2025-06-20SELL-156 15.470* 19.21 Profit of 2,997 on sale
2025-06-12SELL-1,248 16.240* 19.34 Profit of 24,138 on sale
2025-06-02BUY468 16.350* 19.50
2025-05-28BUY310 16.970* 19.56
2025-05-14BUY154 17.810* 19.74
2025-05-13BUY306 20.120* 19.73
2025-05-07BUY462 19.080* 19.74
2025-04-28BUY153 19.780* 19.74
2025-04-16BUY2,002 19.030* 19.79
2025-04-14BUY306 19.050* 19.80
2025-04-08SELL-308 17.750* 19.85 Profit of 6,112 on sale
2025-04-04SELL-310 17.710* 19.88 Profit of 6,164 on sale
2025-03-28BUY1,540 19.460* 19.90
2025-03-24BUY12,751 19.880* 19.90
2025-03-12SELL-252 17.620* 20.03 Profit of 5,047 on sale
2025-03-04SELL-252 18.030* 20.18 Profit of 5,085 on sale
2025-02-26SELL-500 19.040* 20.26 Profit of 10,129 on sale
2025-02-13BUY125 21.700* 20.32
2025-02-12BUY500 24.920* 20.25
2025-01-27BUY124 23.000* 19.31
2025-01-23BUY124 23.420* 19.15
2024-12-09BUY4,536 19.880* 18.94
2024-12-04BUY252 21.010* 18.80
2024-12-03BUY378 20.400* 18.77
2024-11-19BUY762 18.760* 18.39
2024-11-18BUY254 17.470* 18.42
2024-11-12BUY504 18.580* 18.42
2024-11-11BUY126 18.370* 18.42
2024-11-11BUY126 18.370* 18.42
2024-11-07BUY625 18.790* 18.38
2024-11-07BUY625 18.790* 18.38
2024-10-23BUY250 17.910* 18.10
2024-10-23BUY250 17.910* 18.10
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CLBT

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19306,6370597,57151.3%
2025-09-18422,1290729,51357.9%
2025-09-17214,2830399,02653.7%
2025-09-16325,3000552,73258.9%
2025-09-15402,7392,408638,32063.1%
2025-09-12346,590901624,90755.5%
2025-09-11243,2639,400347,76470.0%
2025-09-10523,1133,290817,50564.0%
2025-09-09579,5692,927879,99165.9%
2025-09-08560,150800860,17065.1%
2025-09-05346,2085,522589,93658.7%
2025-09-04941,9731,9392,475,30638.1%
2025-09-03678,51801,013,55366.9%
2025-09-02448,6210708,98963.3%
2025-08-29358,5124,438657,94154.5%
2025-08-28456,1280820,74055.6%
2025-08-27530,6706,301802,77566.1%
2025-08-26320,5931,092436,42673.5%
2025-08-25435,36296,019616,13670.7%
2025-08-22288,0160598,68548.1%
2025-08-21365,1050682,86553.5%
2025-08-20327,05715600,75054.4%
2025-08-19677,75601,082,24262.6%
2025-08-18607,3565,9131,196,11950.8%
2025-08-15983,5991,0252,308,83542.6%
2025-08-142,562,71824,9004,282,57559.8%
2025-08-13485,004419907,33253.5%
2025-08-12290,309268579,26250.1%
2025-08-11312,009918757,41041.2%
2025-08-08191,202207370,61751.6%
2025-08-07225,140205442,46850.9%
2025-08-06150,49736385,46239.0%
2025-08-05145,703129476,86930.6%
2025-08-04131,9690633,69920.8%
2025-08-01168,801397399,08642.3%
2025-07-31177,602624578,06230.7%
2025-07-30201,121825472,31342.6%
2025-07-29155,4371314,15449.5%
2025-07-28166,175415391,08242.5%
2025-07-25156,12261386,00440.4%
2025-07-24254,5031,465630,94640.3%
2025-07-23286,8550714,08240.2%
2025-07-22154,3600336,17145.9%
2025-07-21205,563205627,77332.7%
2025-07-18182,135184417,92543.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.